Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Verification in Pediatric Chronic Graft-Versus-Host Disease: Applied Biomarkers to Minimize Long Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) / Pediatric Transplantation & Cellular Therapy Consortium (PTCTC)

NCT04372524 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04372524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04372524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Verification in Pediatric Chronic Graft-Versus-Host Disease: Applied Biomarkers to Minimize Long Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) / Pediatric Transplantation & Cellular Therapy Consortium (PTCTC)
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Unknown status
Start date
November 15, 2020
Completion date
January 31, 2025
Enrollment
350 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic hematopoietic stem cell transplantation, blood cancer, chronic graft-versus-host-disease, leukemia, non-malignant hematologic and lymphocytic disorder